"Considering Pulmozyme"
Cysitic Fibrosis and Improving Lung Health.
The Importance of Persistence—and Pulmozyme—Every Day
Considering Pulmozyme?
Don’t put it off—ask your doctor whether you can be doing more to delay disease progression with Pulmozyme.Learn more about Pulmozyme and Cystic Fibrosis.
Using Pulmozyme?
Stay committed and proactive—With Pulmozyme, every day matters when it comes to lung health. Learn more about Cystic Fibrosis
You must have Javascript enabled and Flash 8.0 or above to get the full Experience of Pulmozyme.com.
Please download Flash here
Spotlight
Topic:
Successfully Managing Your CF As An Adult
Host:
Dr. Marcia Katz with her patient Casey Flaherty and her mother Paula Flaherty
Date and Time:
August 27, 2009 8:00 PM EST
Learn how to handle the difficult transition from teen to young adulthood and get your questions answered live.
Discover CF Living -
an email program designed to support you with tailored information to help you manage your journey with CF
Watch and listen to how Pulmozyme works.
Explore our videos that give real Pulmozyme patients an opportunity to share their story.
Contribute to the Cystic Fibrosis Community by sharing your experience of living with CF with other patients and caregivers.
Pulmozyme Community
The Pulmozyme Community is a place for people of all ages to connect and learn about life with cystic fibrosis.
Indication and Usage
Daily administration of Pulmozyme in conjunction with standard therapies is indicated in the management of cystic fibrosis (CF) patients to improve pulmonary function. In patients with an FVC ≥40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics.
Safety and efficacy of daily administration have not been demonstrated in patients for longer than 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its ingredients. Pulmozyme should be used in conjunction with standard therapies for CF. When starting Pulmozyme therapy, patients may experience change in or loss of voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose. These side effects are usually mild and short-lived.
Pediatric Use
There is a limited amount of information available concerning the usage of Pulmozyme in patients who are younger than 5 years. The decision to use Pulmozyme in these patients is made after considering the potential for a benefit in lung function or in decreasing the risk of RTEs.
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.
